Vaccination in Newborns and Infants
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 6 of these applications claim priority to application PCT/EP2012/000877, filed Feb 29, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,172,935 | Vaccination in Newborns and Infants In force · High confidence UsedRemaining | Curevac SE | In force | High confidence | ||
| US 10,596,252 | Vaccination in Newborns and Infants In force · High confidence | Curevac SE | In force | High confidence | ||
| US 10,729,761 | Vaccination in Newborns and Infants In force · Medium confidence | Curevac SE | In force | Medium confidence | ||
| US 11,672,856 | Vaccination in Newborns and Infants In force · High confidence | Curevac SE | In force | High confidence | ||
| US 12,390,520 | Vaccination in Newborns and Infants In force · Medium confidence | CureVac SE | In force | Medium confidence | ||
| US 9,623,095 | Vaccination in Newborns and Infants In force · High confidence | Curevac SE | In force | High confidence | ||
| Application 15/437,405 | Vaccination in Newborns and Infants Abandoned Abandoned Nov 4, 2018 | Curevac SE | Abandoned | Abandoned Nov 4, 2018 | ||
| Application 17/067,709 | Vaccination in Newborns and Infants Abandoned Abandoned Jul 27, 2024 | Curevac SE | Abandoned | Abandoned Jul 27, 2024 | ||
| Application 19/029,252 | Vaccination in Newborns and Infants Pending Not granted | CureVac SE | Pending | Not granted | ||
| Application 19/280,019 | Vaccination in Newborns and Infants Pending Not granted | CureVac SE | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.